GMP-Ready Recombinant Human IL-2 Protein

Recombinant Human IL-2 Protein

IL-2

Support T-cell and NK-cell expansion and activation with highly pure, animal origin-free IL-2 complete with regulatory documentation

Human interleukin-2 (IL-2) is a key cytokine that regulates immune responses by driving T-cell and NK-cell proliferation and differentiation. In a dose- and context-dependent manner, IL-2 enhances effector function while supporting regulatory T-cell (Treg) maintenance, enabling balanced immune activation and control.

The IL-2 manufacturing process has been optimized to produce a highly bioactive protein with excellent lot-to-lot consistency for enhanced experimental reproducibility.

Featured applications:

Activation of T-cells and natural killer (NK) cells
Differentiation of T-cells
Development and maintenance of regulatory T-cells (Tregs)
Promotion of the expansion of effector T-cells

Details:

Expressed in E. coli
Animal origin-free (AOF) and carrier protein-free (CF)
Manufactured under a certified ISO 9001:2015 Quality Management System
15.5 kDa monomer
>98%, by SDS-PAGE quantitative densitometry
Lyophilized from acetonitrile, TFA
Reconstitute in sterile-filtered water at >50 μg/mL, add carrier protein if desired, prepare single use aliquots and store frozen at -20°C (short-term) or -80°C (long-term).

Part numbers for research use:

Qk089-0050 = 50 µg
Qk089-0100 = 100 µg
Qk089-0500 = 500 µg

Part number for GMP manufacturing:

Qk089-CTG-0500 = 500 µg

Please download IL-2 resources here:

Sales inquiries

Buy now

Applications

T cells

CAR-T

NK Cells

Car-NK

A core expansion cytokine for T and NK-cell workflows.

High Purity

Recombinant IL-2 migrates at approximately 15.5 kDa (monomer) in reduced (R) and non-reduced (NR) conditions. No contaminating protein bands are present. The purified recombinant protein (3 µg) was resolved using 15% w/v SDS-PAGE in reduced (+β-mercaptoethanol, R) and non-reduced (NR) conditions and stained with Coomassie Brilliant Blue R250. Data from Qk089 lot #204686.

Sales inquiries

Bioactivity

Recombinant IL-2 activity was determined using a SRE luciferase reporter assay in transiently transfected HEK293 cells co-transfected with the IL-2 receptors (IL-2Rβ and IL-2Rγ). Transfected cells were treated in triplicate with a serial dilution of IL-2 for 3 hours. Firefly activity was measured and normalized to the control Renilla luciferase activity. Data from Qk089 lot #204686. EC50 = 0.86 ng/ml (55 pM).

Sales inquiries

How can we help you?

Sales inquiries

Facebook

This field is for validation purposes and should be left unchanged.

Name(Required)

First Name Last Name

Email(Required)

Phone

Company

Country

State

Message

CAPTCHA

Product Background

Interleukin-2 (IL-2/IL2) is a cytokine that plays a vital role in the immune system, particularly in T-cell development, growth, and activity. IL-2 is produced mainly by activated CD4+ T-cells in response to antigenic stimulation and is essential for both immune response amplification and immune regulation [1,2].

IL-2 is a single-chain glycoprotein composed of 133 amino acids with a molecular weight of 15.5 kDa. The IL-2 receptor (IL-2R) is a complex made up of three subunits: IL-2Rα (CD25), IL-2Rβ (CD122), and the common gamma chain (γc, CD132). When IL-2 binds to its receptor, it activates downstream signaling pathways like JAK-STAT and PI3K-AKT, promoting cell survival, proliferation, and differentiation [3].

IL-2 is critical for the expansion of effector T-cells, which are responsible for attacking and eliminating pathogens and cancer cells. It also plays a role in the development and maintenance of regulatory T-cells (Tregs), which prevent autoimmune responses by keeping the immune system in check. IL-2 enhances the activity of natural killer (NK) cells and B-cells, contributing to overall immune defense [4].

IL-2 is used in cancer immunotherapy, particularly for treating metastatic melanoma and renal cell carcinoma, where it boosts the immune system’s ability to attack tumors. Low-dose IL-2 is being investigated for autoimmune diseases such as lupus and type 1 diabetes, where it can promote Treg expansion to restore immune balance. IL-2 has also been explored as a treatment for chronic infections like HIV and hepatitis C by enhancing immune cell recovery and function. Its role as an adjuvant in vaccines and its potential in organ transplantation to promote immune tolerance are also being actively studied [5].

Background references

[1] Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12, 180-190 (2012). https://doi.org/10.1038/nri3156

[2] Liao, W., Lin, J. X. & Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13-25 (2013). doi: 10.1016/j.immuni.2013.01.004

[3] Arenas-Ramirez, N., Woytschak, J. & Boyman, O. Interleukin-2: Biology, design and application. Trends Immunol. 36, 763-777 (2015). doi: 10.1016/j.it.2015.10.003

[4] Spolski, R., Li, P. & Leonard, W. J. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nat. Rev. Immunol. 18, 648-659 (2018). doi: 10.1038/s41577-018-0046-y

[5] Ross, S. H. & Cantrell, D. A. Signaling and function of interleukin-2 in T lymphocytes. Annu. Rev. Immunol. 36, 411-433 (2018). doi: 10.1146/annurev-immunol-042617-053352

Frequently asked questions

What is IL-2?

IL-2 is a cytokine that regulates immune responses by promoting the growth and activation of T-cells, enhancing immune function, and maintaining immune tolerance for immune activation and suppression.

Where is IL-2 found?

IL-2 is found in the immune system, produced by activated CD4+ T-cells, CD8+ T-cells, and natural killer cells, primarily within lymphoid tissues like lymph nodes and the spleen.

Is IL-2 a cytokine?

Yes, IL-2 is a cytokine. Cytokines are small proteins that help regulate the immune system, and IL-2 specifically plays a key role in the activation, growth, and proliferation of T-cells and other immune cells.

What does the IL-2 gene do?

The IL-2 gene encodes interleukin-2, a cytokine crucial for T-cell proliferation, activation, and survival, playing a key role in immune response and regulation.

What does IL-2 bind to?

IL-2 primarily binds to the IL-2 receptor (IL-2R), which has three subunits: alpha (CD25), beta (CD122), and gamma (CD132). This binding initiates signaling pathways such as JAK-STAT, MAPK and PI3K-AKT pathways that promote T-cell growth, differentiation, and survival.

What is the function of the IL-2 receptor?

The IL-2 receptor (IL-2R) mediates interleukin-2 signaling, promoting T-cell proliferation, activation, and survival. It regulates immune responses, maintains immune homeostasis, and stimulates other immune cells, contributing to a balanced and effective adaptive immune response.

What is the IL-2 pathway?

The IL-2 pathway involves IL-2 binding to its receptor, activating JAK kinases, which phosphorylate STAT proteins. This triggers gene expression for T-cell proliferation and survival, while also activating MAPK and PI3K-AKT pathways, enhancing overall immune response and regulation.

How is IL-2 used in cell culture?

IL-2 is utilized in cell culture to promote T-cell growth and proliferation, maintaining cell viability by preventing apoptosis. It aids in differentiating T-cell subsets, supports functional assays for cytokine production, and is used in co-culture systems with other immune cells to study immune interactions and responses effectively.

Disclaimer

For use in manufacturing of cellular or gene therapy products.
Not intended for in vivo applications.